Related Experiment Videos
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
1Alzheimer's Disease Center, Department of Neurology, University of California at Davis, Sacramento, California 95817, USA. cdecarli@ucdavis.edu <cdecarli@ucdavis.edu>
Abstract:
Mild cognitive impairment (MCI) is a recently described syndrome that is currently thought of as a transition phase between healthy cognitive ageing and dementia. Although this notion seems to be reasonable, the general nature of the term MCI--including its many definitions--makes accurate accounting of the prevalence, prognosis, and potential benefit from treatment somewhat difficult. The differences in cognitive profile and clinical progression among individuals with MCI are generally recognised. However, recent evidence also suggests that the aetiological heterogeneity among individuals with MCI could be greater than previously reported. For example, cerebrovascular disease seems to be underestimated as a potential cause of MCI. In this review, I attempt to recognise workable definitions of MCI to discuss the prevalence, pathophysiology, prognosis, and possibilities for treatment of this disorder.
Insights
Mild cognitive impairment (MCI) is a transitional stage between aging and dementia. This review explores MCI definitions, causes like cerebrovascular disease, and treatment options for better understanding and management.
Area of Science:
- Neurology
- Gerontology
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) is recognized as a transitional phase between normal cognitive aging and dementia.
- The broad nature and varying definitions of MCI complicate accurate prevalence, prognosis, and treatment assessments.
- Individual differences in cognitive profiles and clinical progression are acknowledged in MCI.
Purpose of the Study:
- To review and define workable classifications of mild cognitive impairment (MCI).
- To discuss the prevalence, pathophysiology, and prognosis of MCI.
- To explore potential treatment strategies for individuals with MCI.
Main Methods:
- Literature review of existing studies on mild cognitive impairment (MCI).
- Analysis of different MCI definitions and their implications.
- Examination of etiological factors, including cerebrovascular disease.
Main Results:
- The heterogeneity of MCI, particularly etiological factors like cerebrovascular disease, is greater than previously assumed.
- Varied definitions of MCI present challenges in epidemiological and clinical research.
- Cerebrovascular disease is an underrecognized contributor to MCI.
Conclusions:
- Standardized definitions are crucial for advancing MCI research and clinical practice.
- Recognizing the diverse causes of MCI is essential for developing targeted interventions.
- Further research into the pathophysiology and treatment of MCI is warranted.